Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PTPN14 interacts with and negatively regulates the oncogenic function of YAP
Xiayu Liu, N. Yang, Sheila Figel, et al.
Oncogene (2012) Vol. 32, Iss. 10, pp. 1266-1273
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

The Biology of YAP/TAZ: Hippo Signaling and Beyond
Stefano Piccolo, Sirio Dupont, Michelangelo Cordenonsi
Physiological Reviews (2014) Vol. 94, Iss. 4, pp. 1287-1312
Closed Access | Times Cited: 1554
The Hippo pathway: regulators and regulations
Fa‐Xing Yu, Kun‐Liang Guan
Genes & Development (2013) Vol. 27, Iss. 4, pp. 355-371
Open Access | Times Cited: 1156
The Hippo Pathway: Biology and Pathophysiology
Shenghong Ma, Zhipeng Meng, Rui Chen, et al.
Annual Review of Biochemistry (2018) Vol. 88, Iss. 1, pp. 577-604
Closed Access | Times Cited: 1046
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy L. Johnson, Georg Halder
Nature Reviews Drug Discovery (2013) Vol. 13, Iss. 1, pp. 63-79
Open Access | Times Cited: 842
The Hippo signaling pathway in stem cell biology and cancer
Jung‐Soon Mo, Hyun Woo Park, Kun‐Liang Guan
EMBO Reports (2014) Vol. 15, Iss. 6, pp. 642-656
Open Access | Times Cited: 602
YAP and TAZ: a nexus for Hippo signaling and beyond
Carsten Gram Hansen, Toshiro Moroishi, Kun‐Liang Guan
Trends in Cell Biology (2015) Vol. 25, Iss. 9, pp. 499-513
Open Access | Times Cited: 513
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
T. K. B. Gandhi, Wanjin Hong
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 298
Genomics and evolution of protein phosphatases
Jinan Chen, Jack E. Dixon, Gerard Manning
Science Signaling (2017) Vol. 10, Iss. 474
Closed Access | Times Cited: 270
The Hippo Pathway, YAP/TAZ, and the Plasma Membrane
Valentina Rausch, Carsten Gram Hansen
Trends in Cell Biology (2019) Vol. 30, Iss. 1, pp. 32-48
Open Access | Times Cited: 214
Disease implications of the Hippo/YAP pathway
Steven W. Plouffe, Audrey W. Hong, Kun‐Liang Guan
Trends in Molecular Medicine (2015) Vol. 21, Iss. 4, pp. 212-222
Open Access | Times Cited: 211
Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
Wenqi Wang, Nan Li, Xu Li, et al.
Cell Reports (2015) Vol. 13, Iss. 3, pp. 524-532
Open Access | Times Cited: 195
Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression
Xiaomin Cai, Kuei-Chun Wang, Zhipeng Meng
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 180
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Federica Lo Sardo, Paola Muti, Giovanni Blandino, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1913-1913
Open Access | Times Cited: 177
PTPN14 is required for the density-dependent control of YAP1
Wenqi Wang, Jun Huang, Xin Wang, et al.
Genes & Development (2012) Vol. 26, Iss. 17, pp. 1959-1971
Open Access | Times Cited: 188
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Stephano S. Mello, Liz J. Valente, Nitin Raj, et al.
Cancer Cell (2017) Vol. 32, Iss. 4, pp. 460-473.e6
Open Access | Times Cited: 165
ERK1/2 Blockade Prevents Epithelial–Mesenchymal Transition in Lung Cancer Cells and Promotes Their Sensitivity to EGFR Inhibition
Janine M. Buonato, Matthew J. Lazzara
Cancer Research (2013) Vol. 74, Iss. 1, pp. 309-319
Open Access | Times Cited: 162
The Hippo pathway in normal development and cancer
Marcello Maugeri‐Saccà, Ruggero De Maria
Pharmacology & Therapeutics (2018) Vol. 186, pp. 60-72
Open Access | Times Cited: 159
Single-cell analysis of progenitor cell dynamics and lineage specification in the human fetal kidney
Rajasree Menon, Edgar A. Otto, Austin Kokoruda, et al.
Development (2018) Vol. 145, Iss. 16
Open Access | Times Cited: 145
Cell Junctions in Hippo Signaling
Ruçhan Karaman, Georg Halder
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 5, pp. a028753-a028753
Open Access | Times Cited: 124
The regulation and function of YAP transcription co-activator
Chu Zhu, Li Li, Bin Zhao
Acta Biochimica et Biophysica Sinica (2014) Vol. 47, Iss. 1, pp. 16-28
Open Access | Times Cited: 118
Regulation of the Hippo pathway and implications for anticancer drug development
Hyun Woo Park, Kun‐Liang Guan
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 10, pp. 581-589
Open Access | Times Cited: 110
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN
Lijuan Wang, Chenchen He, Xin Sui, et al.
Oncotarget (2015) Vol. 6, Iss. 8, pp. 5932-5946
Open Access | Times Cited: 106
YAP/TAZ for cancer therapy: Opportunities and challenges (Review)
Liwen Guo, Lisong Teng
International Journal of Oncology (2015) Vol. 46, Iss. 4, pp. 1444-1452
Open Access | Times Cited: 106
The roles of the Hippo pathway in cancer metastasis
Helena J. Janse van Rensburg, Xiaolong Yang
Cellular Signalling (2016) Vol. 28, Iss. 11, pp. 1761-1772
Closed Access | Times Cited: 101
The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
Manami Kodaka, Yutaka Hata
Cellular and Molecular Life Sciences (2014) Vol. 72, Iss. 2, pp. 285-306
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top